Phase 2 Study of Epacadostat, Pembrolizumab, and CRS-207, With or Without Cyclophosphamide and GVAX Pancreas Vaccine in Patients With Metastatic Pancreas Cancer
Phase of Trial: Phase II
Latest Information Update: 01 Feb 2018
At a glance
- Drugs CRS 207 (Primary) ; Cyclophosphamide (Primary) ; Epacadostat (Primary) ; Pembrolizumab (Primary) ; Tumour cell vaccine-GVAX (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- 26 Jan 2018 Status changed from not yet recruiting to recruiting.
- 28 Aug 2017 Planned initiation date changed from 1 Jun 2017 to 1 Sep 2017.
- 03 May 2017 Planned initiation date changed from 1 Feb 2017 to 1 Jun 2017.